Context: Pituitary stalk interruption syndrome (PSIS) is characterized by a thin or absent pituitary stalk usually in association with an ectopic posterior pituitary and hypoplasia/aplasia of the anterior pituitary. Associated phenotypes include varied ocular anomalies, hypoglycemia, micropenis/ cryptorchidism, growth failure, or combined pituitary hormone deficiencies. Although genetic causes have been identified, they explain only around 5% of PSIS cases.
T he pituitary gland regulates growth, reproduction, stress response, and metabolism by secreting hormones in response to signals from the hypothalamus. It is entirely ectodermal in origin, but it is composed of two functionally distinct lobes, anterior and posterior, that differ in embryologic development and anatomy (1, 2) . The anterior pituitary develops from Rathke's pouch, which is an upward invagination of oral ectoderm from the roof of the stomodeum. The posterior lobe is derived from the pituitary stalk (infundibulum), which is formed by evagination of the neuroectoderm lining the floor of the ventral diencephalon. The hypothalamo-pituitary axis is established when neuroendocrine neurons located in the paraventricular nucleus and the supraoptic nucleus in the hypothalamus project axons, via the medial ventral midline, that eventually migrate to the median eminence or the posterior pituitary (1, 2) . Genes involved in anterior pituitary development and function have recently been characterized, and several of these genes, including HESX1, LHX3, LHX4, POU1F1, PROP1, SIX6, OTX2, PTX2, GLI2, SOX2, and SOX3, when mutated are associated with a wide range of pituitary phenotypes, including combined pituitary hormone deficiencies and isolated growth hormone deficiency (GHD) (2) (3) (4) (5) (6) . In contrast to the formation of Rathke's pouch and the anterior pituitary, little is known about the genetic factors controlling the development of the pituitary stalk and posterior pituitary.
Pituitary stalk interruption syndrome (PSIS) is characterized by the presence of a thin or absent pituitary stalk (7, 8) . It is commonly associated with an ectopic posterior pituitary and hypoplasia or aplasia of the anterior pituitary that is identified by magnetic resonance imaging. This rare syndrome, usually seen in infancy, can be associated with other midline abnormalities and variable endocrine disorders, including hypoglycemia, micropenis, growth failure, or pituitary hormone deficiencies (7, 8) . The etiology of PSIS is unknown in 95% of cases, although genetic causes are suspected. Mice lacking HesX1, Lhx2, Nkx2.1, Rax, Tbx3, and Hex1/Hes5 double knockouts all fail to form a pituitary stalk (2, 3, 9) . In humans, mutations or sequence variants in six genes have been shown to be involved in PSIS: LHX4, OTX2, HESX1, SOX3, PROKR2, and GPR161 (5, 6, 10, 11).
Here, we used an exome sequencing approach to understand the underlying genetic etiology of PSIS in a series of patients with PSIS. We identified novel variants involving the ROBO1 gene in five individuals from three families with PSIS.
Materials and Methods
Patients, family members, and controls Written, informed consent was given by all the parents and by the patient aged more than 18 years for the evaluation of molecular biology analyses with the use of protocols approved by local and national research ethics committees. The pituitary evaluation and follow-up were conducted as previously described (7, 8) .
Decreased growth rate was defined as a height velocity during the previous year of more than one standard deviation (SD) score below the mean for chronological age or a decrease in height SD of more than 0.5 over 1 year in children older than 2 years. The criterion for diagnosing GHD was a growth hormone peak response of less than 6.7 ng/mL after two pharmacological stimulation tests or during spontaneous hypoglycemia, excluding the response to growth hormone-releasing hormone, with low insulin-like growth factor 1 concentration. These concentrations were expressed as SD score compared with the normal values for age. Thyroid-stimulating hormone deficiency was diagnosed by plasma free T4 below 12 pmol/L. Adrenocorticotropin deficiency was diagnosed by plasma basal cortisol values below 40 ng/mL in neonates and below 80 ng/mL in older children, with no increase during hypoglycemia and low/normal baseline adrenocorticotropin levels. Gonadotropin deficiency was diagnosed by no or partial gonadotropins (luteinizing hormone and follicle-stimulating hormone) response to a gonadotropin-releasing hormone stimulation test. The plasma osmolalities were measured after water deprivation for 12 hours with normal concentrations from 275 to 300 mosmol/kg.
All families in the study were of French ancestry. The control panel consisted of 512 unrelated 46,XY males of French ethnic origin.
DNA sequencing
Exome sequencing was performed using the Illumina HiSeq2000 system at an average coverage of 350 (details in the Supplemental Appendix). In summary, for family 1, both affected siblings and parents were exome sequenced. In family 2, the affected child and both parents were exome sequenced. In family 3, only DNA from the proband was of sufficient quantity for exome sequencing. All candidate pathogenic mutations were confirmed by Sanger sequencing. The patients had been previously screened for mutations in the genes HES1, LHX4, OTX2, and SOX3 by Sanger sequencing, and pathogenic mutations were not detected (4, 12, and unpublished data).
Results
Exome sequencing of 25 cases of PSIS, including two familial cases, identified three novel nonsense, frameshift, and missense mutations in the ROBO1 gene. Details of the rare (minor allelic frequency ,0.001) and novel variants detected in each patient by exome sequencing are summarized in the Supplemental Material. The clinical details of the five PSIS patients carrying potentially pathogenic mutations are summarized in Table 1 , and representative magnetic resonance images are shown in Fig. 1 . Family 1 (patients 1 and 2) consisted of two affected nonidentical twins with PSIS, isolated GHD, and strabismus. The DNA from both affected siblings and their parents was exome sequenced. Analysis of the exome sequencing data set revealed a shared heterozygous frameshift mutation, c.2928_2929delG (ENST00000464233), in the ROBO1 gene. This single base pair deletion is predicted to result in the generation of a downstream termination codon, p.Ala977Glnfs*40 [ Fig. 2(a) ]. The mutation was carried by their phenotypically normal father.
A second sporadic male case of PSIS with isolated GHD and ptosis (patient 3) was identified. Exome sequencing was performed for the child and his parents. Analysis of the data set revealed a heterozygous c.3450G.T (ENST00000464233) substitution that is predicted to generate a stop codon (p.Tyr1150Ter) in ROBO1 [ Fig. 2(a) ]. This mutation was carried by his phenotypically normal mother.
A familial case of PSIS (patients 4 and 5) consisted of an affected 46,XX individual [III-2, Fig. 2(b) ] who presented with combined growth hormone and thyroid-stimulating hormone deficiencies and strabismus. She has an affected paternal aunt (II.3) with complete anterior pituitary deficiency, and her paternal grandfather (I.1) presented with short stature (DNA unavailable for study). The proband and her paternal aunt shared a heterozygous mutation, c.719G.C (ENST00000464233), in ROBO1 that is predicted to result in a p.Cys240Ser amino acid change (PolyPhen2 probably damaging 1.0). The mutation was transmitted by the father of patient 4 (II.2), who has short stature (22 SD), but he was not clinically evaluated for PSIS. This highly conserved amino acid residue is located in the second immunoglobulin-like domain, and it is strictly conserved between ROBO1 to ROBO4 [ Fig. 2(c)  and 2(d) ]. An analysis of rare and novel variants in the exome sequencing data of the proband did not reveal any other candidate gene mutations for the phenotype (Supplemental Tables 1-3) .
These nonsense, frameshift, and missense mutations in ROBO1 were absent from dbSNP138, the Exome Variant Server, the Exome Aggregation Consortium database, our internal database, and the 1000 Genomes Project database. Furthermore, these mutations were not detected in a screen of 512 healthy fertile control individuals of French ancestry. A list of all rare loss-of-function ROBO1 mutations complied from public databases (dbSNP138, Exome Aggregation Consortium, 1000 Genomes Project, and National Heart, Lung, and Blood Institute Exome Sequencing Project) are listed in the Supplemental Table 4 .
Rare variants in PSIS-associated genes, including HESX1, LHX3, LHX4, POU1F1, PROP1, SIX6, OTX2, PTX2, GLI2, SOX2, SOX3, GPR161, and PROKR2, were screened using the exome data set data, and no deleterious variants were identified.
Discussion
ROBO receptors are important regulators of axon guidance and cell migration in vertebrates and invertebrates (13) . Slit guidance ligands (SLITs) are a conserved family of secreted proteins that were originally discovered in the nervous system, where they signal through ROBO receptors to mediate axonal guidance and branching (13) . Classically, Slit/Robo signaling initiates repulsive responses by directing axons to grow away from the source of Slit, thereby restricting commissural axon crossing at the ventral midline within the developing vertebrate spinal cord (14) . Slit/Robo signaling also plays an active role in the process of neuronal outgrowth and branching by promoting axonal elongation, branching in sensory neurons and dendritic growth, and branching in cortical cells (15, 16) . Therefore, depending on the cellular context in response to Slit ligands, Robo signaling promotes repulsion, attraction, or branching. The mammalian genome encodes four ROBO receptors and three SLIT genes, which are the principal ligands for ROBO receptors and are widely expressed in the central nervous system of the developing brain (13, 14) . The involvement of Robo1 in the development of the posterior pituitary of the mouse has not been investigated. Robo1 2/2 mice died at birth, but prenatally, they have defects in axon pathfinding and cortical interneuron migration. The former include dysgenesis of the corpus callosum and hippocampal commissure, as well as abnormalities in corticothalamic and thalamocortical targeting (17) . Here, we identified nonsense, missense, and frameshift mutations in the ROBO1 gene specifically associated with PSIS. Patients 1 and 2 carried a heterozygous ROBO1 c.2928_2929delG mutation that results in a downstream premature termination codon, and in a sporadic case, patient 3 carried a heterozygous p.Tyr1150Ter mutation. The messenger RNAs carrying these nonsense mutations are predicted to be recognized by the nonsense-mediated decay surveillance complexes and degraded. These data indicate that haploinsufficiency of ROBO1 can result in PSIS. A third patient had a mutation for the C240 residue, which is strictly conserved between ROBO1 to ROBO4 and is located in the second immunoglobulin-like domain of ROBO1. The interaction between SLIT2 and ROBO1 proteins is mediated through the immunoglobulin 1 (Ig1) and immunoglobulin 2 (Ig2) domains of ROBO1 and the second leucine-rich repeat (LRR) domain of SLIT2 (17) . Although the ROBO1 Ig1 domain is the primary binding site for the SLIT2 protein, the Ig2 domain harbors a weak secondary SLIT2 binding site that is necessary for SLIT2-ROBO1 signaling (18) . The flexibility of the Ig1 to Ig2 domains could allow Ig2 to simultaneously contact the second LRR domain of SLIT2, while it is primarily bound to Ig1, and this could be part of the ROBO/SLIT signal transduction mechanism that may be disrupted by the p.Cys240Ser mutation in the PSIS patient.
Four of the five patients presented with forms of strabismus or ptosis. Extrapituitary defects such as optic nerve hypoplasia, anophthalmia/microphthalmia, and forebrain defects such as agenesis of the corpus callosum are often seen in association with gene mutations associated with PSIS, suggesting an underlying developmental anomaly of the anterior midline (3). In the four cases described here, we cannot exclude that the mutations in ROBO1 were directly responsible for the ocular anomalies. During eye development, retinal ganglion cell axon extension involves a directed radial pathfinding toward the optic disc in the central retina, where they coalesce to form the optic nerve. Optic nerve axons grow toward the brain. The axons from both eyes converge on each other at the midline of the ventral part of the brain, where they either cross the midline or turn away from it, thereby forming the optic chiasm. There is considerable evidence that Silt/Robo signaling is required for channeling retinal ganglion cell axons from the eye to the brain. Mice lacking Slit1/Slit2 show misrouted axon projection within the retina toward the optic disc (19) . Although both Slit1 and Slit2 signaling pathways prevent premature midline crossing of retinal axons (20, 21) , Slit2 has been shown to make a greater contribution than Slit1 to the guidance of the retinal ganglion cell axons at the optic chiasm, with the chiasm in Slit2 2/2 mutants showing many axons mislocated abnormally anteriorly (22) . Further work has shown that Slit/ Robo signaling may regulate axon pathfinding along the entire optic tract (23, 24) . Slit2 is also required for retinal angiogenesis by signaling through Robo1 and Robo2 receptors, resulting in retinal endothelial proliferation (25) (26) (27) . Although the ROBO1 mutations we describe here are all novel and were not observed in our ancestry-matched controls, in families 1 and 2, the heterozygous mutations were inherited from an unaffected parent. This is similar to previous observations in which, for example, frameshift and missense mutations involving the HESX1 and LHX4 genes are often heterozygous and characterized by a highly variable phenotype among family members and show incomplete penetrance (3, 28) . The genetic background influences the severity of the pituitary phenotype in mice lacking Lhx4 or Prop1, indicating that other, as yet unidentified, variants are contributing to the disease phenotypes (28) .
Our genetic data support a possible role for loss-offunction ROBO1 mutations in ROBO1 in PSIS, but identification of additional patients will be required to confirm this observation in the future. Mendelian diseasecausing genes are less tolerant to coding variations than other genes. Put simply, genes known to carry few common functional variants in healthy individuals may be considered more likely to cause certain diseases. The residual variation intolerance score ranks human genes by their deviation from the genome-wide average number of nonsynonymous mutations found in genes with a similar amount of global mutational burden (http://genic-intolerance.org/) compared with genes known to carry many such variants. The intolerance score is based on allele frequency obtained from whole-exome sequence data within the National Heart, Lung, and Blood Institute-ESP6500 data set. The ROBO1 gene has a residual variation intolerance score of 1.85% and a deficit in loss-of-function variants [percentage ExAC residual variation intolerance score (ExAC_RVIS)] among the 4.93% lowest of the human genome.
The precise mechanism whereby dysregulation of ROBO1 signaling results in PSIS is unknown, but it may involve the Notch effector gene Hes1. Hes1 is spatially and temporally restricted to the developing diencephalon and pituitary during development, and its expression must be silenced for pituitary cell differentiation to occur (29) . Hes1 null embryos lack the posterior pituitary lobe (30) and exhibit abnormal projections of argenine vasopressinpositive axons to the posterior pituitary, indicating that Hes1 may play a role specifically in the guidance of hypothalamic axons to the pituitary (29) . Interestingly, Robo1 has been shown to modulate neurogenesis through the transcriptional modulation of Hes1 (31) . It remains to be determined if the ROBO1 mutations described here affect Notch/Hes1 signaling or cause PSIS by an alternative regulatory pathway.
